Bayer

Summary

Bayer is the famous Corporate Investor, which was founded in 1863. The main office of represented Corporate Investor is situated in the Leverkusen. The fund was located in Europe if to be more exact in Germany.

Among the most popular portfolio startups of the fund, we may highlight BlueRock Therapeutics, OneDrop, Arvegenix. Among the most popular fund investment industries, there are Biotechnology, Agriculture. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Bayer, startups are often financed by Launch Fund, The Yield Lab, St. Louis Arch Angels. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, Ginkgo Bioworks, ARCH Venture Partners. In the next rounds fund is usually obtained by Viking Global Investors, Ginkgo Bioworks.

Deals in the range of 50 - 100 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 38 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2019. When the investment is from Bayer the average startup value is 5-10 millions dollars. Comparing to the other companies, this Bayer performs on 21 percentage points less the average number of lead investments. The top amount of exits for fund were in 2019.

This organization was formed by Friedrich Bayer, Johann Friedrich Weskott.